Recent studies have demonstrated that the high expression of PFKFB4 predicts a poor prognosis in various types of cancer, including breast [45], gastric [46]; lung [47]; melanoma [48]; and thyroid cancer [49]. This evidence concerns the gene PFKFB4 and thyroid gland carcinoma.